Skip to main content

Research

NIH awards WVU $2 million to study link between Alzheimer’s disease, chronic stress

By 2050, 12.8 million Americans age 65 or older are likely to have Alzheimer’s disease. That’s more than double the number who have it today. Paul Chantler—a researcher with the WVU School of Medicine—is investigating the link between Alzheimer’s disease and chronic stress. What he and his team uncover may suggest new ways to slow the disease’s progression or even delay its onset. The National Institute of Neurological Disorders and Stroke awarded the project $2 million.

WVU receives NIH funding to dissect the mechanism of retinal degeneration

Retinal diseases can make even the most mundane tasks—like cooking, driving and walking down the sidewalk—difficult or impossible, and they can’t be cured. WVU School of Medicine researchers Peter Stoilov and Visvanathan Ramamurthy are studying the role that specific proteins play in rapid retinal degeneration. What they learn may lead to new treatments that are more cost-effective and more widely applicable than the treatments available today.

‘Good virus’ may help scientists slow progression of incurable eye disorders

Viruses may have a bad reputation, but with a little help from scientists, some of them can do great things. Wen Tao Deng—a researcher with the WVU School of Medicine—is studying how engineered adeno-associated virus, or AAV, could be used in gene therapy for incurable eye disorders. Her work is relevant to a range of conditions that affect visual acuity and color vision, including red-green colorblindness, the most common form of color deficiency. The National Eye Institute has awarded her project $1.9 million.

WVU issues update following Community Notice

We are grateful there was not an incident on Monday (Dec. 6) as suggested in the anonymous letter the University had received. At this time, safety experts tell WVU it may resume normal operations on campus.